| 发明名称 |
HEPATITIS C INHIBITOR COMPOUNDS |
| 摘要 |
The invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 are defined herein, and their use for the treatment of hepatitis C viral infection. |
| 申请公布号 |
EP2748167(B1) |
申请公布日期 |
2017.03.01 |
| 申请号 |
EP20120825396 |
申请日期 |
2012.08.22 |
| 申请人 |
Boehringer Ingelheim International GmbH |
发明人 |
BROCHU, Christian;GRAND-MAÎTRE, Chantal;JOLY, Marc-André;KUHN, Cyrille;BERTRAND-LAPERLE, Mégan;PESANT, Marc |
| 分类号 |
C07D487/04;A61K31/395;A61K31/4162;A61K31/4196;A61K31/4245;A61K31/437;A61K31/4439;A61K31/454;A61K31/4545;A61K31/497;A61P31/14;C07D513/04 |
主分类号 |
C07D487/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
